Katsiaryna Y. Skapavets

Katsiaryna Y. Skapavets

Auto-generated profile, based on publicly available information

Katsiaryna Y. Skapavets

Belarusian Research Center for Pediatric Oncology, Hematology and Immunology

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in Microbiology Independent Research Journal (MIR Journal)
Verified
Journal Article
Open access
PDF file
KAKatsiaryna V. Akhremchuk
Katsiaryna V. Akhremchuk
KSKatsiaryna Y. Skapavets
Katsiaryna Y. Skapavets
AAArtur E. Akhremchuk
Artur E. Akhremchuk
NKNatalia P. Kirsanava
Natalia P. Kirsanava
ASAnastasiya V. Sidarenka
Anastasiya V. Sidarenka
LVLeonid N. Valentovich
Leonid N. Valentovich
Gut microbiome of healthy people and patients with hematological malignancies in Belarus

31 July 2023 in Pediatric Hematology/Oncology and Immunopathology
Verified
Journal Article
Open access
PDF file
EPEkaterina Polyakova
Ekaterina Polyakova
IGIrina Guryanova
Irina Guryanova
VVVladislav Vertelko
Vladislav Vertelko
ALAliaksandr Liubushkin
Aliaksandr Liubushkin
KSKatsiaryna Y. Skapavets
Katsiaryna Y. Skapavets
MBMikhail Belevtsev
Mikhail Belevtsev
Primary immunodeficiencies are congenital genetically determined immune disorders. Recent advances in molecular genetic technologies have enabled a simultaneous analysis of a large number of genes in a patient. The purpose of this study was to analyze the mutational spectrum in DNA samples collected from patients with various types of primary immunodeficiencies. In this study, we applied next-generation sequencing technology using a panel developed at the Belarusian Research Center for Pediatric Oncology, Hematology and Immunology and consisting of 290 genes that are associated with primary immunodeficiencies according to the existing literature. The testing was carried out in 96 patients with a clinical history suggesting a primary immunological defect. As a result, 37.5% of cases (36/96 patients) were found to harbor genetic defects that lead to disorders of the immune system.

29 November 2022 in Proceedings of the National Academy of Sciences of Belarus, Medical series
Verified
Journal Article
Open access
PDF file
KAK. U. Akhremchuk
K. U. Akhremchuk
KSK. Y. Skapavets
K. Y. Skapavets
AAA. E. Akhremchuk
A. E. Akhremchuk
NKN. P. Kirsanava
N. P. Kirsanava
ASA. V. Sidarenka
A. V. Sidarenka
ЕСЕ. Я. Скоповец
Е. Я. Скоповец
This article describes the first attempt of fecal microbiota transplantation for correction of gut microbiota in two patients suffering from hematologic malignancies made in the Republic of Belarus. Partial clinical response to the procedure was observed in the both patients. We detected positive changes in the gastrointestinal tract state and a decrease in the abundance of multiresistant bacteria. In addition, microorganisms from donor microbiota were observed in intestinal microbiota of the patients. However, the positive effects of fecal microbiota transplantation disappeared after re-initiation of chemotherapy and antibiotics treatment. Further research is required to improve the procedure effectiveness in patients with hematologic malignancies.

1 September 2023 in Proceedings of the National Academy of Sciences of Belarus, Medical series
Verified
Journal Article
Open access
PDF file
EPE. A. Polyakova
E. A. Polyakova
MSM. V. Stegantseva
M. V. Stegantseva
IGI. E. Guryanova
I. E. Guryanova
DLD. V. Lutskovich
D. V. Lutskovich
KSK. Y. Skapavets
K. Y. Skapavets
ЕСЕ. Я. Скоповец
Е. Я. Скоповец
Inborn immunity errors such as primary immunodeficiencies in children represent a significant problem for public health, and it is undeniably important to improve the laboratory diagnosis of this pathology by creating new, effective methods for early detection of disorders involving immune mechanisms.The ROC analysis was used to evaluate the diagnostic significance of determining the copy number of T- and B-cell receptor DNA circle fragments (TREC/KREC) by multiplex real-time PCR in patients with a genetically determined diagnosis of primary immunodeficiency.Peripheral blood DNA samples of healthy children (n = 98) aged 0.0 (0-15.0) years, who constituted the control group, and of patients with genetically confirmed primary immunodeficiency (n = 95) aged 7.2 (0.1-18.0) years were examined.It has been established that determining the number of T and B cell receptor rearrangement products (TREC and KREC) has a high diagnostic significance in severe combined immunodeficiency, chromosomal instability syndromes such as ataxiateleangioectasia and Niimegen syndrome, diseases associated with immune dysregulation, agammoglobulinemia. Determining TREC and KREC is not informative in immunodeficiencies with non-lymphoid cell dysfunction or disorders that do not affect T- and B-cell receptor gene rearrangement such as the Wiskott-Aldrich syndrome and the chronic granulomatous disease.Determining TREC, KREC has a high diagnostic significance and can be applied in diagnosis of congenital immunity errors associated with T- and B-cell lymphopenia.